Cargando…
The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to carefu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726710/ https://www.ncbi.nlm.nih.gov/pubmed/31222393 http://dx.doi.org/10.1007/s00520-019-04925-8 |
_version_ | 1783449131902042112 |
---|---|
author | Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. Epstein, Joel B. de Lange, Jan Smeele, Ludi E. |
author_facet | Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. Epstein, Joel B. de Lange, Jan Smeele, Ludi E. |
author_sort | Zecha, Judith A. E. M. |
collection | PubMed |
description | Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to careful history taking and physical examination including X-rays and microbiological evaluations. Nevertheless, an infection is documented clinically in only 20–30% of cases, whereas a causative microbial pathogen is not identified in over 70% of FN cases. The oral cavity is generally only visually inspected. Although it is recognized that ulcerative oral mucositis may be involved in the development of FN, the contribution of infections of the periodontium, the dentition, and salivary glands may be underestimated. These infections can be easily overlooked, as symptoms and signs of inflammation may be limited or absent during neutropenia. This narrative review is aimed to inform the clinician on the potential role of the oral cavity as a potential source in the development of FN. Areas for future research directed to advancing optimal management strategies are discussed. |
format | Online Article Text |
id | pubmed-6726710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-67267102019-09-17 The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. Epstein, Joel B. de Lange, Jan Smeele, Ludi E. Support Care Cancer Review Article Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to careful history taking and physical examination including X-rays and microbiological evaluations. Nevertheless, an infection is documented clinically in only 20–30% of cases, whereas a causative microbial pathogen is not identified in over 70% of FN cases. The oral cavity is generally only visually inspected. Although it is recognized that ulcerative oral mucositis may be involved in the development of FN, the contribution of infections of the periodontium, the dentition, and salivary glands may be underestimated. These infections can be easily overlooked, as symptoms and signs of inflammation may be limited or absent during neutropenia. This narrative review is aimed to inform the clinician on the potential role of the oral cavity as a potential source in the development of FN. Areas for future research directed to advancing optimal management strategies are discussed. Springer Berlin Heidelberg 2019-06-20 2019 /pmc/articles/PMC6726710/ /pubmed/31222393 http://dx.doi.org/10.1007/s00520-019-04925-8 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. Epstein, Joel B. de Lange, Jan Smeele, Ludi E. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title_full | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title_fullStr | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title_full_unstemmed | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title_short | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
title_sort | impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726710/ https://www.ncbi.nlm.nih.gov/pubmed/31222393 http://dx.doi.org/10.1007/s00520-019-04925-8 |
work_keys_str_mv | AT zechajudithaem theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT raberdurlacherjudithe theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT laheijalexamga theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT westermannannekem theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT epsteinjoelb theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT delangejan theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT smeeleludie theimpactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT zechajudithaem impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT raberdurlacherjudithe impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT laheijalexamga impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT westermannannekem impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT epsteinjoelb impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT delangejan impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy AT smeeleludie impactoftheoralcavityinfebrileneutropeniaandinfectiouscomplicationsinpatientstreatedwithmyelosuppressivechemotherapy |